Overview

An Investigational Study Drug, Palbociclib (PD-0332991), Is Being Studied In Patients With Mantle Cell Lymphoma. Patients Must Have Received Prior Treatment(s) For Mantle Cell Lymphoma.

Status:
Completed

Trial end date:
2012-03-01

Target enrollment:

Participant gender:

Summary

This is a pilot study evaluating tumor activity using Positron Emission Tomography, which is also known as a "PET scan". This study will assess the safety of using PD-0332991 in patients with mantle cell lymphoma.

Phase:

Phase 1

Details

Lead Sponsor:

Pfizer

Treatments:

Palbociclib